Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CITADEL: Citicoline in Preventing Cognitive Decline After Delirium in Older Adults With Proximal Hip Fracture
NCT07804498Phase 2Recruiting
- Sponsor
- University of Milano-Bicocca
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of citicoline in No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity., sponsored by University of Milano-Bicocca. Started Jun 2026; status: recruiting.
02
Drugs
citicoline
03
Conditions
No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity.
Beyond the preview
Go deeper on NCT07804498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07804498.